Cochlear Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CHEOY research report →
About the company
Cochlear Limited is a global healthcare company specializing in advanced auditory solutions. It develops and manufactures surgically implanted hearing devices for individuals of all ages, from children to adults, across the world. The company's diverse product range features cochlear implant systems, enhanced sound processor upgrades, bone conduction technology, and a variety of complementary accessories and related items.
- CEO
- Diggory William Howitt
- IPO
- 2010
- Employees
- 4,996
- HQ
- Sydney, NSW, AU
Price Chart
- Market Cap
- $5.48B
- P/E
- 23.67
- P/S
- 3.46
- P/B
- 4.22
- EV/EBITDA
- 14.84
- Div Yield
- 3.44%
- Gross Margin
- 73.03%
- Op Margin
- 19.98%
- Net Margin
- 14.62%
- ROE
- 17.76%
- ROIC
- 15.72%
- Revenue
- $2.34B · 4.81%
- Net Income
- $388.90M · 9.00%
- EPS
- $2.97 · 9.39%
- Op Income
- $406.10M
- FCF YoY
- -54.85%
- 52W High
- $105.60
- 52W Low
- $31.82
- 50D MA
- $36.34
- 200D MA
- $71.11
- Beta
- 0.26
- Avg Volume
- 87.15K
Get TickerSpark's AI analysis on CHEOY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our CHEOY coverage
Recent articles, reports, and earnings notes.
No research on CHEOY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CHEOY report →Similar companies
Peers in the same neighborhood.